Ischaemic stroke ‘uncommon’ in COVID-19
Patients hospitalised with the infection, however, have a poor prognosis if they do experience stroke, New York doctors say.
Patients hospitalised with the infection, however, have a poor prognosis if they do experience stroke, New York doctors say.
Patients have very high D-dimer levels and many are positive for lupus anticoagulant.
Australian researchers find extensive neurodegeneration three months after stroke.
Â
Â
In contrast with SARS, some patients have neurological symptoms early in the disease course, authors say.
It raises questions about the need for early reinstatement of antithrombotic therapy, say researchers.
Disabling ischaemic stroke more than 30 days post-procedure occurs most frequently, find researchers.
Large registry study suggests higher risk of stroke and bleeding on dual therapy.
Neurologists have taken a step towards unravelling the complexities.
Setting a target of 1.8mmol/L helps avert new cerebrovascular events, say researchers.
Patients on NOACs pre-stroke do not appear to be at increased risk, say researchers.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.